These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 24184155)
1. Low sirtuin 1 levels in human osteoarthritis subchondral osteoblasts lead to abnormal sclerostin expression which decreases Wnt/β-catenin activity. Abed É; Couchourel D; Delalandre A; Duval N; Pelletier JP; Martel-Pelletier J; Lajeunesse D Bone; 2014 Feb; 59():28-36. PubMed ID: 24184155 [TBL] [Abstract][Full Text] [Related]
2. Beneficial effect of resveratrol on phenotypic features and activity of osteoarthritic osteoblasts. Abed É; Delalandre A; Lajeunesse D Arthritis Res Ther; 2017 Jun; 19(1):151. PubMed ID: 28666466 [TBL] [Abstract][Full Text] [Related]
3. Elevated hepatocyte growth factor levels in osteoarthritis osteoblasts contribute to their altered response to bone morphogenetic protein-2 and reduced mineralization capacity. Abed E; Bouvard B; Martineau X; Jouzeau JY; Reboul P; Lajeunesse D Bone; 2015 Jun; 75():111-9. PubMed ID: 25667190 [TBL] [Abstract][Full Text] [Related]
4. Elevated Dickkopf-2 levels contribute to the abnormal phenotype of human osteoarthritic osteoblasts. Chan TF; Couchourel D; Abed E; Delalandre A; Duval N; Lajeunesse D J Bone Miner Res; 2011 Jul; 26(7):1399-410. PubMed ID: 21312269 [TBL] [Abstract][Full Text] [Related]
5. Alteration of Wnt5a expression and of the non-canonical Wnt/PCP and Wnt/PKC-Ca2+ pathways in human osteoarthritis osteoblasts. Martineau X; Abed É; Martel-Pelletier J; Pelletier JP; Lajeunesse D PLoS One; 2017; 12(8):e0180711. PubMed ID: 28777797 [TBL] [Abstract][Full Text] [Related]
6. R-spondins are newly recognized players in osteoarthritis that regulate Wnt signaling in osteoblasts. Abed É; Chan TF; Delalandre A; Martel-Pelletier J; Pelletier JP; Lajeunesse D Arthritis Rheum; 2011 Dec; 63(12):3865-75. PubMed ID: 22127703 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of GSK3β Stimulates BMP Signaling and Decreases SOST Expression Which Results in Enhanced Osteoblast Differentiation. Schoeman MA; Moester MJ; Oostlander AE; Kaijzel EL; Valstar ER; Nelissen RG; Löwik CW; de Rooij KE J Cell Biochem; 2015 Dec; 116(12):2938-46. PubMed ID: 26095393 [TBL] [Abstract][Full Text] [Related]
8. Estrogen Modulates Bone Morphogenetic Protein-Induced Sclerostin Expression Through the Wnt Signaling Pathway. Kim RY; Yang HJ; Song YM; Kim IS; Hwang SJ Tissue Eng Part A; 2015 Jul; 21(13-14):2076-88. PubMed ID: 25837159 [TBL] [Abstract][Full Text] [Related]
9. Effects of SOST Gene Silencing on Proliferation, Apoptosis, Invasion, and Migration of Human Osteosarcoma Cells Through the Wnt/β-Catenin Signaling Pathway. Zou J; Zhang W; Li XL Calcif Tissue Int; 2017 Jun; 100(6):551-564. PubMed ID: 28246931 [TBL] [Abstract][Full Text] [Related]
10. Local leptin production in osteoarthritis subchondral osteoblasts may be responsible for their abnormal phenotypic expression. Mutabaruka MS; Aoulad Aissa M; Delalandre A; Lavigne M; Lajeunesse D Arthritis Res Ther; 2010; 12(1):R20. PubMed ID: 20141628 [TBL] [Abstract][Full Text] [Related]
11. DNA methylation regulates sclerostin (SOST) expression in osteoarthritic chondrocytes by bone morphogenetic protein 2 (BMP-2) induced changes in Smads binding affinity to the CpG region of SOST promoter. Papathanasiou I; Kostopoulou F; Malizos KN; Tsezou A Arthritis Res Ther; 2015 Jun; 17(1):160. PubMed ID: 26071314 [TBL] [Abstract][Full Text] [Related]
12. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. Vincent C; Findlay DM; Welldon KJ; Wijenayaka AR; Zheng TS; Haynes DR; Fazzalari NL; Evdokiou A; Atkins GJ J Bone Miner Res; 2009 Aug; 24(8):1434-49. PubMed ID: 19292615 [TBL] [Abstract][Full Text] [Related]
13. Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts. Massicotte F; Aubry I; Martel-Pelletier J; Pelletier JP; Fernandes J; Lajeunesse D Arthritis Res Ther; 2006; 8(6):R177. PubMed ID: 17129375 [TBL] [Abstract][Full Text] [Related]
14. Wnt-β-catenin signaling pathway inhibition by sclerostin may protect against degradation in healthy but not osteoarthritic cartilage. Wu J; Ma L; Wu L; Jin Q Mol Med Rep; 2017 May; 15(5):2423-2432. PubMed ID: 28259981 [TBL] [Abstract][Full Text] [Related]
15. Pigment epithelium derived factor suppresses expression of Sost/Sclerostin by osteocytes: implication for its role in bone matrix mineralization. Li F; Song N; Tombran-Tink J; Niyibizi C J Cell Physiol; 2015 Jun; 230(6):1243-9. PubMed ID: 25363869 [TBL] [Abstract][Full Text] [Related]
16. Modulation of insulin-like growth factor 1 levels in human osteoarthritic subchondral bone osteoblasts. Massicotte F; Fernandes JC; Martel-Pelletier J; Pelletier JP; Lajeunesse D Bone; 2006 Mar; 38(3):333-41. PubMed ID: 16257278 [TBL] [Abstract][Full Text] [Related]
17. Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production. Couchourel D; Aubry I; Delalandre A; Lavigne M; Martel-Pelletier J; Pelletier JP; Lajeunesse D Arthritis Rheum; 2009 May; 60(5):1438-50. PubMed ID: 19404930 [TBL] [Abstract][Full Text] [Related]
18. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. Lin C; Jiang X; Dai Z; Guo X; Weng T; Wang J; Li Y; Feng G; Gao X; He L J Bone Miner Res; 2009 Oct; 24(10):1651-61. PubMed ID: 19419300 [TBL] [Abstract][Full Text] [Related]